MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$44,273,319
Short-term investments
$14,239,145
Prepaid expenses and
other current assets,...
$2,610,882
Total current assets
$61,123,346
Operating lease
right-of-use assets
$6,542,923
Fixed assets, net
$2,527,603
Investments in affiliated
entity
$2,103,688
Other assets
$2,012,475
Total assets
$74,310,035
Total liabilities and
stockholders equity
$74,310,035
Total liabilities
$50,213,759
Total inovio
pharmaceuticals, inc....
$24,096,276
Accumulated deficit
-$1,815,165,163
Accumulated other
comprehensive loss
-$637,963
Total current
liabilities
$43,668,555
Operating lease
liability, net of current...
$6,545,204
Additional paid-in capital
$1,839,830,405
Common stockpar value
0.001 authorized...
$68,997
Common stock warrant
liabilities
$29,067,162
Accounts payable and
accrued...
$11,053,618
Operating lease liability
$2,822,622
Accrued clinical trial
expenses
$650,680
Accounts payable and
accrued...
$74,473
Back
Back
Balance Sheet
source: myfinsight.com
INOVIO PHARMACEUTICALS, INC. (INO)
INOVIO PHARMACEUTICALS, INC. (INO)